1080MO Sitravatinib plus tislelizumab for metastatic uveal melanoma with liver metastasis: The open-label, multicenter, phase II GEM-2101 trial

Autor: de Carpio Huerta, L.P., Espinosa, E., Cruz Merino, L. de la, Berrocal-Jaime, A., Piulats, J.M.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S716-S716
Databáze: ScienceDirect